Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era
Brachytherapy is a critical component of the standard-of-care curative radiotherapy regimen for women with locally advanced cervical cancer (LACC). However, existing literature suggests that many patients will not receive the brachytherapy boost. We used machine learning (ML) and explainable artificial intelligence to characterize this disparity.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Colton Ladbury, Nicholas Eustace, Ari Kassardjian, Arya Amini, Yi-Jen Chen, Edward Wang, Adrian Kohut, Ana Tergas, Ernest Han, Mihae Song, Scott Glaser Tags: Review Article Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | COVID-19 | Learning | Universities & Medical Training | Women